NeuroPace NPCE
NASDAQ NPCE
$7.56 -4.46 (-37.10%)
At close: Nov 13, 2026 · 4:00 PM EST

NeuroPace (NPCE) Long-Term Debt Repayments (2020)

Updated

Analysis

NeuroPace (NPCE) Long-Term Debt Repayments (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn 1.11 Bn
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn 1.33 Bn
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn -
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn -
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn -
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn -
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn -
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn -
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn 7.00 Mn
10 NeuroPace 260.31 Mn 44.34 Mn 19.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -1,000.00
Sep 30, 2020 42.12 Mn
API Access

NeuroPace Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=NPCE&period=max&api_key=YOUR_API_KEY